Antidepressants Flashcards
monoamine hypothesis
reserpine used for HTN found to cause depression - depleted DA, 5HT, NE
iproniazid/isoniazid - lift depression - inhibit MAO
“depression d/t lowered monoamine NT in synapses - achieve tx via restoring monoamine levels”
isocarboxazid
MAOI
phenelzine
MAOI
traylcypromine
MAOI
selegiline
MAOI
MAOI MOA
mitochondrial enzyme MAO is inhibited = inactivates excess NE, DA, and 5HT that may leak out – they escape degradation
MAO-A: metabolizes NE and 5HT
MAO-B: metabolizes DA and tyramine
antidepressant effect correlates with MAO-A inhibition
hydrazine derivative MAOI
phenelzine
isocarboxazid
non-hydrazine derivative MAOI
tranylcypromine
selegiline
which MAOIs bind irreversibly and nonselectively to MAO-A and MAO-B
phenelzine
isocarboxazid
tranylcypromine
which MAOI only binds MAO-B
selegiline
which MAOI is approved for early tx parkinsons
selegiline
MAOI use
rarely used b/c of AE
used when other tx’s are ineffective
MAOI AE
drowsiness
orthostatic hypotension
weight gain
muscle pain
- serotonin syndrome: hyperthermia, muscle rigidity, myoclonus
- MAOI + serotinergic drug
- cheese reaction
- tyramine causes release of catecholamines = tachycardia, HTN, arrhythmias, seizures
(also seen with sympathomimetic drugs - pseudoephedrine and phenylpropanoloamine)
which MAOI is less likely to cause tyramine induced HTN crisis
selegiline transdermal patch
tx of cheese reaction
phentolamine
prazosin
amitriptyline
TCA
clomipramine
tCA
desipramine
TCA
imipramine
TCA
nortriptyline
TCA
TCA MOA
block SERT and NET = increased MA in cleft
TCA AE
blockade of alpha (orthostatic hypotension, reflex tachy)
- muscarinic (blurred vision, xerostomia, urinary retention) - histamine (sedation, weight gain)
- cardiac fast sodium channels (arrhythmias)
TCA OD tx
sodium bicarbonate - reverse conduction block
citalopram
SSRI
escitalopram
SSRI
fluoxetine
SSRI
fluvoxamine
SSRI